Helping a patient? Use the Family & Caregiver Guide to organize symptoms, reports, medicines, questions, and follow-up safely. Open caregiver guide →
Diet question? Use the Nutrition & Diet Guide to prepare food, hydration, supplement, and medicine-timing questions safely. Open nutrition guide →
Thinking about prevention? Use a simple prevention plan to organize risk factors, protective habits, screening, and warning signs. Open prevention guide →
Thinking about recovery? Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up after illness, injury, surgery, or treatment. Open recovery guide →
Planning treatment? Prepare questions about treatment choices, benefits, risks, side effects, and follow-up before your doctor visit. Open planner →
Disease article roadmap: Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Open roadmap →
Not sure where to begin? Use the RX Start Here page to choose the right patient pathway for symptoms, reports, medicines, or urgent warning signs. Start here →
Blood Cancer Drugs/This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved but are widely used.
The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in leukemia that are not listed here.
Drugs Approved for Acute Lymphoblastic Leukemia (ALL)
- Arranon (Nelarabine)
- Asparaginase Erwinia chrysanthemi
- Asparlas (Calaspargase Pegol-mknl)
- Besponsa (Inotuzumab Ozogamicin)
- Blinatumomab
- Blincyto (Blinatumomab)
- Calaspargase Pegol-mknl
- Cerubidine (Daunorubicin Hydrochloride)
- Clofarabine
- Clolar (Clofarabine)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Daunorubicin Hydrochloride
- Dexamethasone
- Doxorubicin Hydrochloride
- Erwinaze (Asparaginase Erwinia Chrysanthemi)
- Gleevec (Imatinib Mesylate)
- Iclusig (Ponatinib Hydrochloride)
- Inotuzumab Ozogamicin
- Imatinib Mesylate
- Kymriah (Tisagenlecleucel)
- Marqibo (Vincristine Sulfate Liposome)
- Mercaptopurine
- Methotrexate
- Nelarabine
- Oncaspar (Pegaspargase)
- Pegaspargase
- Ponatinib Hydrochloride
- Prednisone
- Purinethol (Mercaptopurine)
- Purixan (Mercaptopurine)
- Rubidomycin (Daunorubicin Hydrochloride)
- Sprycel (Dasatinib)
- Tisagenlecleucel
- Trexall (Methotrexate)
- Vincristine Sulfate
- Vincristine Sulfate Liposome
Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL)
- Hyper-CVAD
Drugs Approved for Acute Myeloid Leukemia (AML)
- Arsenic Trioxide
- Azacitidine
- Cerubidine (Daunorubicin Hydrochloride)
- Cyclophosphamide
- Cytarabine
- Daunorubicin Hydrochloride
- Daunorubicin Hydrochloride and Cytarabine Liposome
- Daurismo (Glasdegib Maleate)
- Dexamethasone
- Doxorubicin Hydrochloride
- Enasidenib Mesylate
- Gemtuzumab Ozogamicin
- Gilteritinib Fumarate
- Glasdegib Maleate
- Idamycin PFS (Idarubicin Hydrochloride)
- Idarubicin Hydrochloride
- Idhifa (Enasidenib Mesylate)
- Ivosidenib
- Midostaurin
- Mitoxantrone Hydrochloride
- Mylotarg (Gemtuzumab Ozogamicin)
- Onureg (Azacitidine)
- Rubidomycin (Daunorubicin Hydrochloride)
- Rydapt (Midostaurin)
- Tabloid (Thioguanine)
- Thioguanine
- Tibsovo (Ivosidenib)
- Trisenox (Arsenic Trioxide)
- Venclexta (Venetoclax)
- Venetoclax
- Vincristine Sulfate
- Vyxeos (Daunorubicin Hydrochloride and Cytarabine Liposome)
- Xospata (Gilteritinib Fumarate)
Drug Combinations Used in Acute Myeloid Leukemia (AML)
- ADE
Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Elzonris (Tagraxofusp-erzs)
- Tagraxofusp-erzs
Drugs Approved for Chronic Lymphocytic Leukemia (CLL)
- Acalabrutinib
- Alemtuzumab
- Arzerra (Ofatumumab)
- Bendamustine Hydrochloride
- Bendeka (Bendamustine Hydrochloride)
- Calquence (Acalabrutinib)
- Campath (Alemtuzumab)
- Chlorambucil
- Copiktra (Duvelisib)
- Cyclophosphamide
- Dexamethasone
- Duvelisib
- Fludarabine Phosphate
- Gazyva (Obinutuzumab)
- Ibrutinib
- Idelalisib
- Imbruvica (Ibrutinib)
- Leukeran (Chlorambucil)
- Mechlorethamine Hydrochloride
- Mustargen (Mechlorethamine Hydrochloride)
- Obinutuzumab
- Ofatumumab
- Prednisone
- Rituxan (Rituximab)
- Rituxan Hycela (Rituximab and Hyaluronidase Human)
- Rituximab
- Rituximab and Hyaluronidase Human
- Treanda (Bendamustine Hydrochloride)
- Truxima (Rituximab)
- Venclexta (Venetoclax)
- Venetoclax
- Zydelig (Idelalisib)
Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL)
- CHLORAMBUCIL-PREDNISONE
- CVP
Drugs Approved for Chronic Myelogenous Leukemia (CML)
- Bosulif (Bosutinib)
- Bosutinib
- Busulfan
- Busulfex (Busulfan)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Dexamethasone
- Gleevec (Imatinib Mesylate)
- Hydrea (Hydroxyurea)
- Hydroxyurea
- Iclusig (Ponatinib Hydrochloride)
- Imatinib Mesylate
- Mechlorethamine Hydrochloride
- Mustargen (Mechlorethamine Hydrochloride)
- Myleran (Busulfan)
- Nilotinib
- Omacetaxine Mepesuccinate
- Ponatinib Hydrochloride
- Sprycel (Dasatinib)
- Synribo (Omacetaxine Mepesuccinate)
- Tasigna (Nilotinib)
Drugs Approved for Hairy Cell Leukemia/Drugs For Blood Cancer
- Cladribine
- Intron A (Recombinant Interferon Alfa-2b)
- Lumoxiti (Moxetumomab Pasudotox-tdfk)
- Moxetumomab Pasudotox-tdfk
- Recombinant Interferon Alfa-2b
Drugs Approved for Mast Cell Leukemia
- Midostaurin
- Rydapt (Midostaurin)
Drugs Approved for Meningeal Leukemia
- Cytarabine
Details List of Cancer Drugs
https://rxharun.com/resources/category/resources/rxharun/article-types/drug-a-z/drugs-for-blood-cancer-fda-approved-drugs-a-to-z/?
References
[bg_collapse view=”button-orange” color=”#4a4949″ expand_text=”Show More” collapse_text=”Show Less” ]
- https://www.ncbi.nlm.nih.gov/books/NBK531459/
- https://www.ncbi.nlm.nih.gov/books/NBK22180/
- https://www.ncbi.nlm.nih.gov/books/NBK65916/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940291/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447524/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415732/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243359/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656269/
- https://link.springer.com/chapter/10.1007/978-3-540-34506-0_1
- https://www.cambridge.org/core/chronic-myeloid-leukemia
- https://medlineplus.gov/genetics/condition/chronic-myeloid-leukemia/
- https://www.nhs.uk/conditions/chronic-myeloid-leukaemia/treatment/
- https://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq
- https://www.cancer.gov/about-cancer/treatment/drugs/leukemia
- https://en.wikipedia.org/wiki/Chronic_myelogenous_leukemia
- https://www.cancertherapyadvisor.com/hospital-medicine/chronic-myeloid-leukemia/
[/bg_collapse]
